BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19806504)

  • 21. Current development of lentiviral-mediated gene transfer.
    Romano G
    Drug News Perspect; 2005 Mar; 18(2):128-34. PubMed ID: 15883621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrase-defective lentiviral vectors: progress and applications.
    Banasik MB; McCray PB
    Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
    Segura MM; Kamen A; Garnier A
    Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector.
    Podsakoff GM
    Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
    Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
    Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentiviral vectors: turning a deadly foe into a therapeutic agent.
    Trono D
    Gene Ther; 2000 Jan; 7(1):20-3. PubMed ID: 10680011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lentiviral vectors for gene therapy of heart disease.
    Higuchi K; Medin JA
    J Cardiol; 2007 Jan; 49(1):1-11. PubMed ID: 17269208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
    Hallek M; Wendtner CM
    Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-primate lentiviral vectors.
    Poeschla EM
    Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.
    Scherr M; Battmer K; Eder M; Schüle S; Hohenberg H; Ganser A; Grez M; Blömer U
    Gene Ther; 2002 Dec; 9(24):1708-14. PubMed ID: 12457285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
    Copreni E; Penzo M; Carrabino S; Conese M
    Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
    Gropp M; Reubinoff B
    Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-viral and viral vectors for gene therapy.
    Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shuttle of lentiviral vectors via transplanted cells in vivo.
    Blömer U; Gruh I; Witschel H; Haverich A; Martin U
    Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.